Direct Marketing
The Journal of Diabetes, Metabolism and Endocrinology is committed to conducting all direct marketing and promotional activities in a transparent, ethical, responsible, and non-misleading manner. Direct marketing may be used to communicate relevant information about the journal, its publications, calls for papers, special issues, conferences, editorial opportunities, and other legitimate scholarly activities.
1. Purpose of Direct Marketing
The journal may use direct marketing to inform relevant members of the academic and research community about:
- Calls for manuscript submissions.
- New issues and recently published articles.
- Special issues and thematic collections.
- Editorial and reviewer opportunities.
- Journal announcements.
- Academic events or activities.
- Relevant publishing services and updates.
Marketing communications should have a legitimate connection to the recipient's scholarly or professional interests.
2. Responsible and Ethical Communication
All direct marketing communications should be:
- Accurate.
- Transparent.
- Professionally written.
- Relevant to the recipient.
- Respectful of applicable privacy and communication requirements.
- Free from deceptive or misleading claims.
The journal will not intentionally make false claims regarding its indexing status, impact, acceptance rates, peer-review process, publication timelines, editorial board, affiliations, or publication services.
3. No Misleading Solicitation
The journal will not use deceptive practices to encourage manuscript submissions.
Marketing communications should not:
- Guarantee manuscript acceptance.
- Guarantee favorable peer review.
- Misrepresent the likelihood of publication.
- Falsely claim indexing or accreditation.
- Misrepresent editorial-board membership.
- Use fabricated metrics or rankings.
- Conceal relevant publication charges.
- Make unsupported claims about the journal's reputation or impact.
4. Targeted Academic Communication
Where direct communication is used, the journal aims to target individuals who are reasonably relevant to the journal's subject areas.
Communications may be directed toward:
- Researchers.
- Authors.
- Academics.
- Healthcare professionals.
- Reviewers.
- Editors.
- Research institutions.
- Academic organizations.
The journal seeks to avoid indiscriminate mass solicitation.
5. Email Marketing
Where email is used for direct marketing, messages should clearly identify:
- The journal or publisher.
- The purpose of the communication.
- Appropriate contact information.
- Where applicable, an option to discontinue future promotional communications.
The journal will not knowingly use misleading sender information, deceptive subject lines, or impersonation.
6. Protection of Personal Information
Personal information obtained for communication purposes should be handled in accordance with the journal's Privacy Policy and applicable data-protection requirements.
The journal will take reasonable measures to prevent unauthorized access, disclosure, or misuse of contact information.
Personal information should not be sold or improperly disclosed to unrelated third parties for their independent marketing purposes.
7. Opt-Out and Unsubscribe
Recipients may request that they no longer receive promotional communications from the journal.
Upon receiving a valid opt-out request, the journal will take reasonable steps to remove the recipient from the relevant promotional mailing list, except where retention of contact information is necessary for legitimate administrative, legal, editorial, or transactional purposes.
8. Authors and Existing Contacts
The journal may communicate with authors, reviewers, editors, and other existing contacts regarding matters directly related to their submissions, publications, editorial responsibilities, or legitimate journal activities.
Administrative or transactional communications are distinguished from promotional marketing where appropriate.
9. Advertising and Sponsorship
Any advertising or sponsorship associated with direct marketing must comply with the journal's Advertising Policy and must not improperly influence editorial decisions.
Commercial relationships must remain separate from:
- Manuscript evaluation.
- Peer review.
- Editorial decisions.
- Research-integrity investigations.
- Corrections and retractions.
10. Third-Party Marketing Services
Where third-party platforms or service providers are used to distribute communications, the journal expects such providers to maintain appropriate safeguards for personal information and comply with applicable contractual and legal requirements.
The journal remains responsible for ensuring that its marketing practices are consistent with its ethical and privacy commitments.
11. Frequency of Communication
The journal aims to maintain a reasonable frequency of promotional communications.
The Editorial Office will seek to avoid excessive, repetitive, or irrelevant messaging that could reasonably be considered spam.
12. Editorial Independence
Direct marketing activities must never influence editorial decisions.
A person's response or failure to respond to promotional communication will not affect:
- Manuscript acceptance.
- Peer-review decisions.
- Editorial consideration.
- Publication priority.
- Author treatment.
- Reviewer selection.
13. Commitment to Responsible Scholarly Promotion
The Journal of Diabetes, Metabolism and Endocrinology uses direct marketing only as a means of communicating legitimate scholarly information and expanding awareness of relevant journal activities.
The journal is committed to transparent, accurate, targeted, and non-deceptive academic communication and will continuously review its marketing practices to ensure that they remain consistent with responsible publishing standards and applicable ethical and privacy requirements.
